Escientia Life Sciences
Narasimha Raju Uppalapati has extensive work experience in the pharmaceutical industry, starting in 1993 with Dr. Reddy's Laboratories as a chemist and progressing to the role of Deputy Manager. Narasimha Raju then moved on to Nicholas Piramal India Ltd as a Pharmacy Manager, where they managed two production blocks and achieved significant milestones. After that, they worked at Mylan as a Sr. Manager, taking care of commercial production and gaining exposure to regulatory audits. Narasimha Raju continued their career at Eisai as an AGM, Pharma, responsible for drug substance activities and pilot plant operations, ensuring compliance with safety and GMP standards. Narasimha Raju'smost recent role was as Associate Vice President at Escientia Life Sciences, where they joined a green field project and was involved in equipment installation, piping, equipment qualification, and implementing quality systems. Throughout their various roles, Narasimha has consistently focused on achieving organizational objectives while maintaining product quality and compliance.
Narasimha Raju Uppalapati completed their education from 1989 to 1992 at MR Model High School. Following this, they pursued a degree in Geology, Physics, and Chemistry at MRA College.
This person is not in any offices
Escientia Life Sciences
Modern science and engineering are revolutionizing the way medicines are made. We are at the cutting-edge of continuous processing, green chemistry, and increased reliability in pharmaceutical manufacturing. Escientia is a premier American technology-oriented manufacturing partner to the largest and most innovative pharma and biotech companies, and governments seeking to secure critical supply chains. Escientia was founded in 2007 by Dr. Yadagiri Pendri, Chairman and Chief Executive Officer, who has led the company to become a preferred partner to the global innovative pharmaceutical industry over the last 15 years. The company's co-founder and President, Kiran Pendri, leads Escientia's efforts to constantly expand its capabilities and capacity. Escientia's global headquarters and research laboratories are in South Windsor, Connecticut, in the United States. Additionally, Escientia has a development hub in Hyderabad, Telangana, and one of the world's most modern pharmaceutical manufacturing parks, located in Vizag, Andhra Pradesh, both in India.